|
Category: information only not used for fragrances or flavors
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Appearance: | white to tan crystalline powder (est) |
| Assay: | 95.00 to 100.00 %
|
| Food Chemicals Codex Listed: | No |
| Melting Point: | 148.00 to 151.00 °C. @ 760.00 mm Hg
|
| Boiling Point: | 299.00 to 300.00 °C. @ 760.00 mm Hg (est)
|
| Vapor Pressure: | 0.001000 mmHg @ 25.00 °C. (est) |
| Flash Point: | 259.00 °F. TCC ( 126.20 °C. ) (est)
|
| logP (o/w): | 2.030 |
| Soluble in: |
| | water, 345 mg/L @ 15 °C (exp) |
Organoleptic Properties:
| |
| |
| Flavor Type: phenolic |
| |
| | phenolic |
| |
| Odor and/or flavor descriptions from others (if found). |
| |
| |
Cosmetic Information:
Suppliers:
Safety Information:
| Preferred SDS: View |
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
intraperitoneal-mouse LD50 200 mg/kg National Technical Information Service. Vol. AD277-689
parenteral-frog LD50 91 mg/kg PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE)
BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES Archives Internationales de Pharmacodynamie et de Therapie. Vol. 124, Pg. 212, 1960.
oral-rat LD > 500 mg/kg National Academy of Sciences, National Research Council, Chemical-Biological Coordination Center, Review. Vol. 5, Pg. 29, 1953.
|
| Dermal Toxicity: |
subcutaneous-mouse LD50 1.13 mg/kg Archives Internationales de Pharmacodynamie et de Therapie. Vol. 124, Pg. 212, 1960.
subcutaneous-mouse LD50 1130 ug/kg LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE)
BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) Archives Internationales de Pharmacodynamie et de Therapie. Vol. 124, Pg. 212, 1960.
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | information only not used for fragrances or flavors |
| Recommendation for 4-hydroxypropiophenone usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for 4-hydroxypropiophenone flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
References:
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| | ethyl p-hydroxyphenyl ketone | | | ethyl para-hydroxyphenyl ketone | | 1-(4- | hydroxy-phenyl)-propan-1-one | | p- | hydroxyl propiophenone | | p- | hydroxyphenyl-1-propanone | | 1-(4- | hydroxyphenyl)-1-propanone | | 1-(p- | hydroxyphenyl)-1-propanone | | 1-(4- | hydroxyphenyl)propan-1-one | | 4'- | hydroxypropiophenone | | p- | hydroxypropiophenone | | | hypophenon | | | ibiopopp | | | paraoxypropiophenone | | | paroxypropion | | | paroxypropione | | 1- | propanone, 1-(4-hydroxyphenyl)- | | 4- | propionylphenol | | p- | propionylphenol | | p- | propiophenol | | | propiophenone, 4'-hydroxy- | | | proxiphenon | | | sterofenon |
Articles:
|